0001670747-25-000003.txt : 20250711 0001670747-25-000003.hdr.sgml : 20250711 20250711131641 ACCESSION NUMBER: 0001670747-25-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20250711 DATE AS OF CHANGE: 20250711 EFFECTIVENESS DATE: 20250711 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BirchBioMed Inc. CENTRAL INDEX KEY: 0001670747 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-551459 FILM NUMBER: 251118381 BUSINESS ADDRESS: STREET 1: 130 KINGSCROSS DRIVE CITY: KING CITY STATE: A6 ZIP: L7B 1E6 BUSINESS PHONE: 866-350-1993 MAIL ADDRESS: STREET 1: 130 KINGSCROSS DRIVE CITY: KING CITY STATE: A6 ZIP: L7B 1E6 D 1 primary_doc.xml X0708 D LIVE 0001670747 BirchBioMed Inc. 130 KINGSCROSS DRIVE KING CITY A6 ONTARIO, CANADA L7B 1E6 905-833-3414 BRITISH COLUMBIA, CANADA None None Corporation true Mark Miller 130 Kingscross Drive King City A6 ONTARIO, CANADA L7B 1E6 Executive Officer Director Promoter John Verbeck 130 Kingscross Drive King City A6 ONTARIO, CANADA L7B 1E6 Executive Officer Susan Elliott 130 Kingscross Drive King City A6 ONTARIO, CANADA L7B 1E6 Executive Officer Director Promoter Carlos Camozzi 130 Kingscross Drive King City A6 ONTARIO, CANADA L7B 1E6 Executive Officer Teresa Bair 130 Kingscross Drive King City A6 ONTARIO, CANADA L7B 1E6 Director Charles Ellis 130 Kingscross Drive King City A6 ONTARIO, CANADA L7B 1E6 Director Joseph Sardano 130 Kingscross Drive King City A6 ONTARIO, CANADA L7B 1E6 Director Herve Girsault 130 Kingscross Drive King City A6 ONTARIO, CANADA L7B 1E6 Executive Officer Biotechnology Decline to Disclose 06b false 2025-06-27 false true true true false 0 3000000 175000 2825000 false 5 0 0 0 false BirchBioMed Inc. /s/ Mark S. Miller Mark S. Miller Chief Executive Officer 2025-07-11